title: Pre- and intratherapeutical ibritumomab tiuxetan Zevalin® dosimetry in childhood.
authors.forename: C
authors.initials: C
authors.lastname: Happel
authors.forename: J
authors.initials: J
authors.lastname: Diener
authors.forename: W T
authors.initials: WT
authors.lastname: Kranert
authors.forename: B
authors.initials: B
authors.lastname: Bockisch
authors.forename: J
authors.initials: J
authors.lastname: Pinkert
authors.forename: F
authors.initials: F
authors.lastname: Grünwald
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D002051:Burkitt Lymphoma / Q000175:diagnosis* / Q000628:therapy*; D002648:Child; D006801:Humans; D018796:Immunoconjugates / Q000008:administration & dosage*; D008297:Male; D011874:Radiometry; D019275:Radiopharmaceuticals / Q000627:therapeutic use; D011879:Radiotherapy Dosage; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D018796:Immunoconjugates; D019275:Radiopharmaceuticals; C422802:ibritumomab tiuxetan